Biosafety and Withdrawal Period of In‐Feed Administered Antiparasitic Drug Emamectin Benzoate in Cirrhinus mrigala (Hamilton, 1822)
Journal of Veterinary Pharmacology and Therapeutics · 2025
DOI: 10.1111/jvp.13495 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Veterinary Pharmacology and Therapeutics, 2025. Verfasst von H G Solanki und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Aquaculture, College of Fisheries Science, Kamdhenu University, Navsari, Gujarat, India. Hauptthemen laut MEDLINE: Ivermectin, Antiparasitic Agents, Fish Diseases, Carps. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 26 Literaturangaben. Gefördert von: Indian Council of Agricultural Research, Ministry of Agriculture and Farmer's Welfare, Government of India.
Abstract (Originalsprache)
Parasitic infestations are one of the most economically important disease conditions in the Indian major carps including mrigal, Cirrhinus mrigala . This study reported the biosafety and tissue withdrawal of in‐feed administered antiparasitic drug, emamectin benzoate (EMB). To evaluate the biosafety of the drug, behaviour, growth and tissue changes in Cirrhinus mrigala was recorded the following in‐feed administration of EMB up to 10 times (T1–50 μg kg −1 fish day −1 (1×), T2–125 μg kg −1 fish day −1 (2.5×), T3–250 μg kg −1 fish day −1 (5×), T4–375 μg kg −1 fish day −1 (7.5×) and T5–500 μg kg −1 fish day −1 (10×)) for the period of three times the recommended duration (7 days). The withdrawal period was calculated by feeding EMB at 50 μg kg −1 fish day −1 for consecutive 10 days followed by EMB‐free feed. The results revealed that the drug is safe to mrigal up to ten times the recommended dose, while the fish fed with the highest dose (500 μg kg −1 fish day −1 ) showed transient histological alterations. The feeding behaviour is affected with poor acceptability beyond 5× dosages. The drug residue at the concentration below the MRL (1.0 μg g −1 ) in the muscle tissue on the day of cessation of medicated feed administration indicates no requirement of the withdrawal period. The study suggests that EMB can be safely used at 50 μg kg −1 fish day −1 for 7 consecutive days, and no withdrawal period is required without affecting the feeding behaviour and tissue histological alterations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Aquaculture, College of Fisheries Science, Kamdhenu University, Navsari, Gujarat, India.
- Aquatic Animal Health and Environment Division, Central Institute of Brackishwater Aquaculture (CIBA), Chennai, India.
- Department of Veterinary Pathology, College of Veterinary Science and Animal Husbandry, Kamdhenu University, Junagadh, Gujarat, India.
- ICAR-Central Institute of Fisheries Technology, Kochi, India.
ORCID-Profile: H G Solanki, H K Solanki, R A Raja, S Avunje, B J Trangadia, S K Panda, P K Patil
Förderung
- Indian Council of Agricultural Research
- Ministry of Agriculture and Farmer's Welfare, Government of India
Zitieren
APA
Solanki, H. G., Verma, A., Solanki, H. K., Raja, R. A., Avunje, S., Trangadia, B. J., Panda, S. K., & Patil, P. K. (2025). Biosafety and Withdrawal Period of In‐Feed Administered Antiparasitic Drug Emamectin Benzoate in Cirrhinus mrigala (Hamilton, 1822). Journal of Veterinary Pharmacology and Therapeutics. https://doi.org/10.1111/jvp.13495
Vancouver
Solanki HG, Verma A, Solanki HK, Raja RA, Avunje S, Trangadia BJ, et al. Biosafety and Withdrawal Period of In‐Feed Administered Antiparasitic Drug Emamectin Benzoate in Cirrhinus mrigala (Hamilton, 1822). Journal of Veterinary Pharmacology and Therapeutics. 2025. doi:10.1111/jvp.13495
BibTeX
@article{Solanki2025,
author = {Solanki, H G and Verma, A and Solanki, H K and Raja, R A and Avunje, S and Trangadia, B J and Panda, S K and Patil, P K},
title = {Biosafety and Withdrawal Period of In‐Feed Administered Antiparasitic Drug Emamectin Benzoate in Cirrhinus mrigala (Hamilton, 1822)},
journal = {Journal of Veterinary Pharmacology and Therapeutics},
year = {2025},
doi = {10.1111/jvp.13495}
}
EUVIMED